D'Amato Michael 4/A
4/A · Evolent Health, Inc. · Filed Aug 14, 2019
Insider Transaction Report
Form 4/AAmended
D'Amato Michael
Director
Transactions
- Purchase
Class A Common Stock
2019-03-11$12.45/sh+10,000$124,500→ 38,212 total
Footnotes (1)
- [F1]Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.